The global counterfeit drug trade: patient safety and public health risks.
about
A call for a moratorium on the .health generic top-level domain: preventing the commercialization and exclusive control of online health informationGeneric medicines: an evaluation of the accuracy and accessibility of information available on the InternetResponding to the pandemic of falsified medicines.Why the MDGs need good governance in pharmaceutical systems to promote global health.Pharmaceutical digital marketing and governance: illicit actors and challenges to global patient safety and public health.Public health measures to fight counterfeit medicine market.Emerging and reemerging neglected tropical diseases: a review of key characteristics, risk factors, and the policy and innovation environment.Health domains for sale: the need for global health Internet governance.Improving global health governance to combat counterfeit medicines: a proposal for a UNODC-WHO-Interpol trilateral mechanismAn exploration of counterfeit medicine surveillance strategies guided by geospatial analysis: lessons learned from counterfeit Avastin detection in the US drug supply chain.Microbiological contamination in counterfeit and unapproved drugs.Counterfeit drug penetration into global legitimate medicine supply chains: a global assessmentPublic health concerns for anti-obesity medicines imported for personal use through the internet: a cross-sectional studyOnline availability and safety of drugs in shortage: a descriptive study of internet vendor characteristics.The tragedy caused by fake antimalarial drugs.Oncology and the Internet: regulatory failure and reform.Online, direct-to-consumer access to insulin: patient safety considerations and reform.Global reach of direct-to-consumer advertising using social media for illicit online drug salesAddressing the impact of economic sanctions on Iranian drug shortages in the joint comprehensive plan of action: promoting access to medicines and health diplomacy.Digital social media, youth, and nonmedical use of prescription drugs: the need for reform.Substandard and counterfeit medicines: a systematic review of the literature.Exploring Consumer and Patient Knowledge, Behavior, and Attitude Toward Medicinal and Lifestyle Products Purchased From the Internet: A Web-Based Survey.Evaluating aspects of online medication safety in long-term follow-up of 136 Internet pharmacies: illegal rogue online pharmacies flourish and are long-lived.Digital danger: a review of the global public health, patient safety and cybersecurity threats posed by illicit online pharmacies.Quality of medicines in Canada: a retrospective review of risk communication documents (2005-2013)After counterfeit Avastin®--what have we learned and what can be done?[Survey of counterfeit oral antiinfectives medecine sold in Lubumbashi].Mapping of Health Communication and Education Strategies Addressing the Public Health Dangers of Illicit Online Pharmacies.A review of existing and emerging digital technologies to combat the global trade in fake medicines.Public health interventions to protect against falsified medicines: a systematic review of international, national and local policies.Trade is central to achieving the sustainable development goals: a case study of antimicrobial resistance.Validated RP-HPLC method for simultaneous determination and quantification of chlorpheniramine maleate, paracetamol and caffeine in tablet formulation.Stem cells, dot-com.What gastroenterologists should know about the gray market, herbal remedies, and compounded pharmaceuticals and their regulation by the Food and Drug Administration.Illicit online marketing of lorcaserin before DEA scheduling.Illicit Internet availability of drugs subject to recall and patient safety consequences.An assessment of pregnant women's knowledge and use of the Internet for medication safety information and purchase.An optical authentication system based on imaging of excitation-selected lanthanide luminescence.Comparative dissolution study on counterfeit medicines of PDE-5 inhibitors.Challenges in treating pediatric asthma in developing countries.
P2860
Q28655409-34988BA7-8DB9-4CED-B83E-D73F16E3BD54Q28661314-FA772EF8-95CA-4119-A5F0-2903CDFFE346Q30062161-FA623558-6239-4D9D-A417-036B035ACD3AQ30392389-ED1BC39D-1E4B-4FAB-A7ED-58EE8FBABAF4Q33592410-E48239E7-5B95-420D-A3A0-FFF6C3D74614Q33600920-F420349F-397F-4822-BCF6-2BB50B2078E4Q34297640-610EBC56-D4DA-4814-9D76-3EB9FF127FACQ34408443-8DE0B9E9-6471-44BE-B18D-D7A8168EB23FQ34478121-894E1751-742F-42F2-BED9-E8D66E4D36A8Q34635245-9C88BEEB-4136-4F47-B32D-E5711E6AE5BEQ35195014-5F87DABB-C50A-4671-AFF5-B6D444B269EDQ35681817-FF2F6EDF-FBDB-47EC-8CF9-9BD3E5E86EF4Q35963093-3B3DE56F-60B5-4639-8C5B-59027D2905B0Q36029738-4DBF5FD9-63EC-49DE-B8BC-C7DEBC972A8DQ36033614-041AD5EF-487B-4D8B-AD40-5DD501F26D03Q36406068-C4D48B4D-D97F-4A06-BF46-DFD8FE186EADQ36605859-EDE79F69-FBF5-40C8-BE11-15DEE88CA02FQ36890165-6486B66C-4520-4038-A6AC-9310241391AFQ36980956-782ED108-C56B-4A57-B3E1-9A21B9952F09Q37092419-4CA3D706-B993-4AB9-82C0-D3B5B3D004ADQ37117268-DAF5C514-D2C1-4FBD-9641-227576B418EEQ37144418-E3DF4721-A530-465A-97AE-CB6BFE9023DBQ37204710-8F5AC268-2F34-466A-A734-B073708C7D27Q37451505-626C7028-3F13-472E-A58D-9DCD216726C3Q38264191-711AF6A4-867A-4AEF-971E-D07070F333E8Q38367161-87694D01-ED09-4099-9F35-278F47FF5C45Q38662417-779D56DC-9F60-44A5-A53A-2BE0DA954053Q38723325-4109B326-3165-4FC6-AD89-D871A2CB1995Q38738669-99B29FF4-C4E3-4A7E-9C63-A50C051A2E08Q38867438-D9860638-8929-4970-80E3-6F67E0A9DF98Q39044433-C336BDF0-654B-43AC-99C0-686FFB55FC28Q41883211-F6B45889-E01C-4772-9DF3-040BB355F7C1Q43957462-3FF4878F-491C-4EE1-A556-81EB57976DCBQ43971429-CDD8EC28-ED81-4903-B947-129DCE7EF833Q44724521-F42F8C6F-4772-4FAE-A7DC-EBB1D02AA09FQ46556031-1CA50831-5C38-4D4A-8F93-3F68AD337635Q48022380-06D77AD9-9049-4467-ACED-6112DA6A052CQ48128776-BF5E4CF5-4A5D-4C23-982E-594A15C5BD50Q49620407-B7D87621-D2DF-4914-9E77-A75590BF2F5EQ50503512-84B381DC-7A36-4F51-A9E2-74F357CD8C3A
P2860
The global counterfeit drug trade: patient safety and public health risks.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
The global counterfeit drug trade: patient safety and public health risks.
@en
The global counterfeit drug trade: patient safety and public health risks.
@nl
type
label
The global counterfeit drug trade: patient safety and public health risks.
@en
The global counterfeit drug trade: patient safety and public health risks.
@nl
prefLabel
The global counterfeit drug trade: patient safety and public health risks.
@en
The global counterfeit drug trade: patient safety and public health risks.
@nl
P356
P1476
The global counterfeit drug trade: patient safety and public health risks.
@en
P2093
Bryan A Liang
P304
P356
10.1002/JPS.22679
P407
P577
2011-06-22T00:00:00Z